Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-22
DOI
10.1038/s41467-021-22617-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endothelial FGFR1 (Fibroblast Growth Factor Receptor 1) Deficiency Contributes Differential Fibrogenic Effects in Kidney and Heart of Diabetic Mice
- (2020) Jinpeng Li et al. HYPERTENSION
- Biomarkers and the role of mast cells as facilitators of inflammation and fibrosis in chronic kidney disease
- (2019) Evan P. Owens et al. Translational Andrology and Urology
- microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney
- (2019) Swayam Prakash Srivastava et al. Frontiers in Pharmacology
- Influence of IL-6, IL-10, IFN-γ and TNF-α genetic variants on susceptibility to diabetic kidney disease in type 2 diabetes mellitus patients
- (2018) Shadia A. Fathy et al. BIOMARKERS
- Role of the Immune System in Diabetic Kidney Disease
- (2018) Fionnuala B. Hickey et al. Current Diabetes Reports
- A Metabolic Basis for Endothelial-to-Mesenchymal Transition
- (2018) Jianhua Xiong et al. MOLECULAR CELL
- Endothelial Cell Metabolism
- (2018) Guy Eelen et al. PHYSIOLOGICAL REVIEWS
- Fatty Acid Oxidation Regulates the Activation of Endothelial-to-Mesenchymal Transition
- (2018) Sara Lovisa et al. TRENDS IN MOLECULAR MEDICINE
- SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis
- (2018) Swayam Prakash Srivastava et al. Cell Death & Disease
- Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury
- (2018) Hua-Lin Zhou et al. NATURE
- Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction
- (2017) Weier Qi et al. NATURE MEDICINE
- FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway
- (2017) Jinpeng Li et al. Cell Death & Disease
- MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy
- (2017) Zhanmei Zhou et al. Cell Death & Disease
- Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury
- (2017) Han Zhou et al. Scientific Reports
- Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy
- (2016) Anna Rita Cantelmo et al. CANCER CELL
- PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection
- (2016) Mei T. Tran et al. NATURE
- The next generation of therapeutics for chronic kidney disease
- (2016) Matthew D. Breyer et al. NATURE REVIEWS DRUG DISCOVERY
- Glycolytic regulation of cell rearrangement in angiogenesis
- (2016) Bert Cruys et al. Nature Communications
- Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis
- (2016) Swayam Prakash Srivastava et al. Scientific Reports
- Endothelial Glucocorticoid Receptor Suppresses Atherogenesis—Brief ReportSignificance
- (2015) Julie E. Goodwin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition
- (2015) Sen Shi et al. KIDNEY INTERNATIONAL
- Fatty acid carbon is essential for dNTP synthesis in endothelial cells
- (2015) Sandra Schoors et al. NATURE
- Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
- (2015) Sara Lovisa et al. NATURE MEDICINE
- New Insights Into Molecular Mechanisms of Diabetic Kidney Disease
- (2014) Shawn S. Badal et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Linagliptin-Mediated DPP-4 Inhibition Ameliorates Kidney Fibrosis in Streptozotocin-Induced Diabetic Mice by Inhibiting Endothelial-to-Mesenchymal Transition in a Therapeutic Regimen
- (2014) Keizo Kanasaki et al. DIABETES
- Interleukin-6 Signaling Drives Fibrosis in Unresolved Inflammation
- (2014) Ceri A. Fielding et al. IMMUNITY
- Molecular mechanisms of diabetic kidney disease
- (2014) Kimberly Reidy et al. JOURNAL OF CLINICAL INVESTIGATION
- Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development
- (2014) Hyun Mi Kang et al. NATURE MEDICINE
- Interferon gamma (IFN-γ)-mediated inflammation and the kynurenine pathway in relation to risk of hip fractures: the Hordaland Health Study
- (2014) E. M. Apalset et al. OSTEOPOROSIS INTERNATIONAL
- Loss of the Endothelial Glucocorticoid Receptor Prevents the Therapeutic Protection Afforded by Dexamethasone after LPS
- (2014) Julie E. Goodwin et al. PLoS One
- Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy
- (2013) Michal Herman-Edelstein et al. JOURNAL OF LIPID RESEARCH
- Origin and function of myofibroblasts in kidney fibrosis
- (2013) Valerie S LeBleu et al. NATURE MEDICINE
- MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT
- (2013) Swayam Prakash Srivastava et al. Biomed Research International
- Randomized comparison of pitavastatin and pravastatin treatment on the reduction of urinary albumin in patients with type 2 diabetic nephropathy
- (2012) S. Kimura et al. DIABETES OBESITY & METABOLISM
- Endothelial glucocorticoid receptor is required for protection against sepsis
- (2012) J. E. Goodwin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endothelial–mesenchymal transition and its contribution to the emergence of stem cell phenotype
- (2012) Damian Medici et al. SEMINARS IN CANCER BIOLOGY
- Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study
- (2011) R.-D. Ting et al. DIABETES CARE
- Effects of Lipid-Lowering Therapy with Rosuvastatin on Kidney Function and Oxidative Stress in Patients with Diabetic Nephropathy
- (2011) Masanori Abe et al. Journal of Atherosclerosis and Thrombosis
- Wnt/β-Catenin Pathway in Podocytes Integrates Cell Adhesion, Differentiation, and Survival
- (2011) Hideki Kato et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
- (2010) SHARP Collaborative Group AMERICAN HEART JOURNAL
- Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin1
- (2010) M. K. Rutter et al. DIABETIC MEDICINE
- Mechanisms of Tubulointerstitial Fibrosis
- (2010) M. Zeisberg et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)
- (2009) Helen M. Colhoun et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis
- (2009) Benjamin D. Humphreys et al. AMERICAN JOURNAL OF PATHOLOGY
- Wnt/ -Catenin Signaling Promotes Renal Interstitial Fibrosis
- (2009) W. He et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition
- (2008) E. M. Zeisberg et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search